BioCryst Pharmaceuticals
BCRX
#5113
Rank
NZ$2.70 B
Marketcap
NZ$12.85
Share price
-1.52%
Change (1 day)
-5.28%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): -NZ$13.18 Million

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.59 Billion. In 2024 the company made an earning of -NZ$0.15 Billion, an increase over its 2023 earnings that were of -NZ$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$13.18 Million-91.2%
2024 -NZ$0.15 Billion-61.56%
2023 -NZ$0.39 Billion-7.43%
2022 -NZ$0.43 Billion34.42%
2021 -NZ$0.32 Billion-0.55%
2020 -NZ$0.32 Billion67.88%
2019 -NZ$0.19 Billion7.55%
2018 -NZ$0.18 Billion53.92%
2017 -NZ$0.12 Billion19.29%
2016 -NZ$94.92 Million28.19%
2015 -NZ$74.05 Million-4.8%
2014 -NZ$77.78 Million50.09%
2013 -NZ$51.83 Million-23.29%
2012 -NZ$67.56 Million-26.19%
2011 -NZ$91.53 Million54.78%
2010 -NZ$59.14 Million150.1%
2009 -NZ$23.65 Million-49.43%
2008 -NZ$46.76 Million14.07%
2007 -NZ$40.99 Million-49.31%
2006 -NZ$80.87 Million72.87%
2005 -NZ$46.78 Million22.08%
2004 -NZ$38.32 Million75.3%
2003 -NZ$21.86 Million-25.36%
2002 -NZ$29.29 Million225.05%
2001 -NZ$9.01 Million-56.6%
2000 -NZ$20.76 Million50.63%
1999 -NZ$13.79 Million38.05%
1998 -NZ$9.99 Million-52.46%
1997 -NZ$21 Million58.44%
1996 -NZ$13.26 Million-14.44%
1995 -NZ$15.5 Million28.57%
1994 -NZ$12.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
NZ$44.99 M-495.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-NZ$0.44 Billion 3,711.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$16.3 Million 43.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.64 B-5,767.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.01 B-149,503.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion 3,772.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.04 B-140,993.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
NZ$0.28 B-2,598.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$42.56 Million 273.65%๐Ÿ‡บ๐Ÿ‡ธ USA